| Zarxio |
125553 |
002 |
351(k) Biosimilar |
filgrastim-sndz |
Injection |
Intravenous, Subcutaneous |
480MCG/0.8ML |
Pre-Filled Syringe |
2015/03/06
|
Sandoz Inc. |
Rx |
Licensed |
filgrastim |
Neupogen |
| Toujeo |
206538 |
001 |
351(a) |
insulin glargine |
Injection |
Subcutaneous |
450UNITS/1.5ML (300UNITS/ML) |
Autoinjector |
2015/02/25
|
Sanofi-Aventis U.S. LLC |
Rx |
Licensed |
N/A |
N/A |
| Norditropin |
021148 |
011 |
351(a) |
somatropin |
Injection |
Subcutaneous |
30MG/3ML |
Autoinjector |
2015/01/23
|
Novo Nordisk Inc. |
Rx |
Licensed |
N/A |
N/A |
| Natpara |
125511 |
001 |
351(a) |
parathyroid hormone |
For Injection |
Subcutaneous |
25MCG |
Multi-Dose Vial |
2015/01/23
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
N/A |
N/A |
| Natpara |
125511 |
002 |
351(a) |
parathyroid hormone |
For Injection |
Subcutaneous |
50MCG |
Multi-Dose Vial |
2015/01/23
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
N/A |
N/A |
| Natpara |
125511 |
003 |
351(a) |
parathyroid hormone |
For Injection |
Subcutaneous |
75MCG |
Multi-Dose Vial |
2015/01/23
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
N/A |
N/A |
| Natpara |
125511 |
004 |
351(a) |
parathyroid hormone |
For Injection |
Subcutaneous |
100MCG |
Multi-Dose Vial |
2015/01/23
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
N/A |
N/A |
| Bexsero |
125546 |
001 |
351(a) |
Meningococcal Group B Vaccine |
Injection |
Intramuscular |
0.5ML |
Pre-Filled Syringe |
2015/01/23
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Cosentyx |
125504 |
001 |
351(a) |
secukinumab |
Injection |
Subcutaneous |
150MG/ML |
Autoinjector |
2015/01/21
|
Novartis Pharmaceuticals Corporation |
Rx |
Licensed |
N/A |
N/A |
| Cosentyx |
125504 |
002 |
351(a) |
secukinumab |
Injection |
Subcutaneous |
150MG/ML |
Pre-Filled Syringe |
2015/01/21
|
Novartis Pharmaceuticals Corporation |
Rx |
Licensed |
N/A |
N/A |
| Cosentyx |
125504 |
003 |
351(a) |
secukinumab |
For Injection |
Subcutaneous |
150MG |
Single-Dose Vial |
2015/01/21
|
Novartis Pharmaceuticals Corporation |
Disc |
Licensed |
N/A |
N/A |
| Keytruda |
125514 |
002 |
351(a) |
pembrolizumab |
Injection |
Intravenous |
100MG/4ML (25MG/ML) |
Single-Dose Vial |
2015/01/15
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
N/A |
N/A |
| Neulasta Onpro |
125031 |
002 |
351(a) |
pegfilgrastim |
Injection |
Subcutaneous |
6MG/0.6ML |
Pre-Filled Syringe |
2014/12/23
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Opdivo |
125554 |
001 |
351(a) |
nivolumab |
Injection |
Intravenous |
40MG/4ML (10MG/ML) |
Single-Dose Vial |
2014/12/22
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Opdivo |
125554 |
002 |
351(a) |
nivolumab |
Injection |
Intravenous |
100MG/10ML (10MG/ML) |
Single-Dose Vial |
2014/12/22
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent |
103914 |
008 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intradermal |
36UG/.5ML |
Pre-Filled Syringe |
2014/12/11
|
Sanofi Pasteur Inc. |
Disc |
Licensed |
|
N/A |
| Gardasil 9 |
125508 |
001 |
351(a) |
Human Papillomavirus 9-valent Vaccine, Recombinant |
Injection |
Intramuscular |
0.5ML |
Pre-Filled Syringe |
2014/12/10
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
|
N/A |
| Gardasil 9 |
125508 |
002 |
351(a) |
Human Papillomavirus 9-valent Vaccine, Recombinant |
Injection |
Intramuscular |
0.5ML |
Single-dose vial |
2014/12/10
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
|
N/A |
| Blincyto |
125557 |
001 |
351(a) |
blinatumomab |
For Injection |
Intravenous |
35MCG |
Single-Dose Vial |
2014/12/03
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Lemtrada |
103948 |
002 |
351(a) |
alemtuzumab |
Injection |
Intravenous |
12MG/1.2ML (10MG/ML) |
Single-Dose Vial |
2014/11/14
|
Genzyme Corporation |
Rx |
Licensed |
N/A |
N/A |